Published by Iain Gilbert on 24th October 2022
(Sharecast News) - Biotechnology business Benchmark said on Monday that following "strong" Q3 results and "a continued positive performance" throughout the rest of the fiscal year, it had experienced better-than-expected trading across its three business areas in Q4.
URL: http://www.digitallook.com/dl/news/story/33054635/...